[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-359872-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-359872-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-apcc-subunit-apc7-promotes-hepatocellular-carcinoma-progression-by-mediating-ubiquitination-and-degradation-of-lats1-to-activate-yaptaz","The APC/C subunit APC7 promotes hepatocellular carcinoma progression by mediating ubiquitination and degradation of LATS1 to activate YAP/TAZ","","The anaphase-promoting complex/cyclosome (APC/C) is an E3 ubiquitin ligase critical for cell cycle regulation, yet the disease-specific roles of its individual subunits in hepatocellular carcinoma (HCC) remain incompletely defined. This study integrates pan-cancer expression and survival analyses with immune profiling and CIBERSORT-based infiltration estimates to pinpoint APC7. Functional and mechanistic experiments use loss- and gain-of-function approaches, RNA sequencing, and ubiquitination assays to show APC7 drives HCC progression via LATS1 ubiquitin-dependent degradation and Hippo/YAP/TAZ activation, indicating therapeutic and prognostic value.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-apcc-subunit-apc7-promotes-hepatocellular-carcinoma-progression-by-mediating-ubiquitination-and-degradation-of-lats1-to-activate-yaptaz/359872/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-apcc-subunit-apc7-promotes-hepatocellular-carcinoma-progression-by-mediating-ubiquitination-and-degradation-of-lats1-to-activate-yaptaz/359872.png","ImageObject",300,407,{"name":42,"@type":43},"Sarah ","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",5,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does APC/C APC7 do in hepatocellular carcinoma progression?","Question",{"text":63,"@type":64},"APC7 promotes HCC malignant progression by facilitating proliferation, migration, invasion, and cell-cycle progression through Hippo signaling activation.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the role of APC7 in HCC investigated?",{"text":68,"@type":64},"The study combined pan-cancer expression/prognosis analysis, immune subtype and immune cell infiltration assessment, and gain- and loss-of-function experiments in HCC.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the proposed mechanism linking APC7 to Hippo pathway activation?",{"text":72,"@type":64},"APC7 interacts with CDH1 to mediate ubiquitin-dependent degradation of LATS1 at K860, leading to YAP/TAZ activation.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},359872,1790168076,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,100,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Comic",60,"comic",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},6,"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":117,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":103,"preview_page_count":33,"preview_urls":144},962085320529,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Sun et al. Biology Direct (2026) 21:56 [https://doi.org/10.1186/s13062-026-00759-7](https://doi.org/10.1186/s13062-026-00759-7)  \nBiology Direct  \nRESEARCH Open Access  \nThe APC/C subunit APC7 promotes   \nhepatocellular carcinoma progression by mediating ubiquitination and degradation of LATS1 to activate YAP/TAZ  \nYing Sun1,2†, Renyu Zhang1,2†, Yilin Guo1,2†, Dong Wu1,2†, Haolin Wei1,2, Zhice Tan1,2, Minmin Huang1,2, Yutong Wang1,2, Zhongyuan Fang1,2, Cong Zhang1,2, Can Li1,2, Wenliang Li1,2, Ding Wei1,2, Huijie Bian1,2* and Ze-Kun Liu 1,2,3*  \nAbstract  \nBackground The anaphase-promoting complex/cyclosome (APC/C) is a multi-subunit E3 ubiquitin ligase critically involved in cell cycle regulation. However, the pathological functions of its individual subunits, particularly in hepatocellular carcinoma (HCC), remain largely unexplored.  \nAim To systematically analyze the expression and prognosis of APC/C in pan-cancer, and also focus on studying the function and mechanism of APC7 in the progression of HCC.  \nMethods Transcriptome data were downloaded from TCGA, ICGC, and GEO databases. The analysis of differential expression genes and clinical characteristics were performed to identify the key APC gene. Moreover, immune subtype analysis was conducted to elucidate potential functions, and immune cell infiltration was assessed using the CIBERSORT algorithm. Then, gain-and loss‐of‐function studies were employed to elucidate the role of APC7 in HCC. Finally, RNA sequencing and ubiquitination assays were employed to elucidate the underlying mechanisms ofAPC7 in HCC.  \nResults This study systematically analyzed the expression and prognosis of various subunits ofthe APC/C complex in pan-cancer samples, and identified APC7 as a key subunit in HCC. APC7 exhibited the most significant upregulation in HCC and was closely associated with poor prognosis in patients. Moreover, the expression profiles of APC7 is closely related to immune checkpoint genes and tumor-infiltrating immune cells. The results of multiplex immunohistochemistry showed that APC7 overexpression markedly increased the infiltration of Foxp3⁺, CD25⁺,  \n†Ying Sun, Renyu Zhang, Yilin Guo and Dong Wu contributed equally to this work.  \n*Correspondence:  \nHuijie Bian [hjbian@fmmu.edu.cn](hjbian@fmmu.edu.cn)[ ](hjbian@fmmu.edu.cn)Ze-Kun Liu [liuzekun1@fmmu.edu.cn](liuzekun1@fmmu.edu.cn)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nand CD4⁺ Treg cells. Functional studies demonstrated that the knockdown of APC7 inhibited HCC cell proliferation, migration, invasion, and G1/S phase transition, whereas overexpression of APC7 promoted these malignant phenotypes in vitro and in vivo. Mechanistically, RNA sequencing and molecular studies revealed that APC7 interacts with CDH1 to mediate ubiquitin-dependent degradation of LATS1 at K8","cbCaitDuU9cNtopR","https://ap.wps.com/l/cbCaitDuU9cNtopR","pdf",15956189,"English","# Abstract\n## Background\n## Aim\n## Methods\n## Results\n## Conclusions\n# Highlights","[{\"question\":\"What does APC/C APC7 do in hepatocellular carcinoma progression?\",\"answer\":\"APC7 promotes HCC malignant progression by facilitating proliferation, migration, invasion, and cell-cycle progression through Hippo signaling activation.\"},{\"question\":\"How was the role of APC7 in HCC investigated?\",\"answer\":\"The study combined pan-cancer expression/prognosis analysis, immune subtype and immune cell infiltration assessment, and gain- and loss-of-function experiments in HCC.\"},{\"question\":\"What is the proposed mechanism linking APC7 to Hippo pathway activation?\",\"answer\":\"APC7 interacts with CDH1 to mediate ubiquitin-dependent degradation of LATS1 at K860, leading to YAP/TAZ activation.\"}]","The APC/C subunit APC7 promotes hepatocellular carcinoma progression by mediating ubiquitination and degradation of LATS1 to activate YAP/TAZ | PDF",1790138075,[145,149,153,157],{"page_no":22,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d57d9fed095243294721856cc2b457a1.webp",983,1310,{"page_no":26,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c1794418e5590b493b6b9482b23df55.webp",982,1309,{"page_no":30,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/12a21dc590462ee2108f3ad0c6b49387.webp",981,1308,{"page_no":33,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33cd14b5457c429fad6ba9f2fc90f17b.webp",980,1306]